NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
09/12/2023
Back to search
Official data from USPTO
EXPRESS SCRIPTS PHARMACY
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
32
Latest update
09/12/2023
Classification
Registered
Trademark type
Combined
Nice classes
9, 35, 44
Filing date
08/21/2020
Registration date
09/12/2023
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
09/12/2023
Last transaction
09/12/2023
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
2020-10-00
First use in commerce
2020-10-00
Drawing code
5
Owner type
03
Owner location
St. Louis, MO
Examiner
CALLERY, TIMOTHY JOHN
Law office
L70
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the words "EXPRESS SCRIPTS PHARMACY" with the "X" of "EXPRESS" consisting of broken lines.
Holders and representatives
Holders
Express Scripts Strategic Development, Inc.
Representatives
Troy E. Larson CIGNA INTELLECTUAL PROPERTY, INC.
Technical classification
Nice Classes
Class 9Class 35Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 9
Downloadable computer application software for providing information regarding prescription medications; downloadable computer application software for pharmacy patients to receive information and updates regarding pharmacy orders, and renewals and alerts regarding prescription medications
Class 35
Mail order pharmacy services; providing consumer product and pricing information in the field of pharmaceuticals; Drug utilization review services
Class 44
Healthcare services, namely, wellness and disease management programs; Consulting services in the field of health in the nature of Medicare prescription drug coverage plan services, namely, complex case management services in the nature of providing health consultation services to patients with chronic conditions regarding medication compliance, and providing information regarding health and safety issues regarding chronic conditions, disease management and providing information regarding health and safety issues regarding chronic conditions; providing information in the field of healthcare; providing information in the fields of healthcare and information regarding the therapeutic properties of pharmaceuticals
Publications
History of USPTO decisions and trademark events.
32 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
09/12/2023
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
08/10/2023
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
08/09/2023
SUPC
STATEMENT OF USE PROCESSING COMPLETE
03/25/2023
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
03/24/2023
IUAF
USE AMENDMENT FILED
03/10/2023
EISU
TEAS STATEMENT OF USE RECEIVED
03/10/2023
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
09/16/2022
EX3G
SOU EXTENSION 3 GRANTED
09/14/2022
EXT3
SOU EXTENSION 3 FILED
09/14/2022
EEXT
SOU TEAS EXTENSION RECEIVED
09/14/2022
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
03/16/2022
EX2G
SOU EXTENSION 2 GRANTED
03/14/2022
EXT2
SOU EXTENSION 2 FILED
03/14/2022
EEXT
SOU TEAS EXTENSION RECEIVED
03/14/2022
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
09/18/2021
EX1G
SOU EXTENSION 1 GRANTED
09/16/2021
EXT1
SOU EXTENSION 1 FILED
09/16/2021
EEXT
SOU TEAS EXTENSION RECEIVED
09/16/2021
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
03/16/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01/19/2021
PUBO
PUBLISHED FOR OPPOSITION
01/19/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
12/30/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/14/2020
XAEC
EXAMINER'S AMENDMENT ENTERED
12/14/2020
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
12/14/2020
GNEA
EXAMINERS AMENDMENT E-MAILED
12/14/2020
CNEA
EXAMINERS AMENDMENT -WRITTEN
12/14/2020
DOCK
ASSIGNED TO EXAMINER
12/01/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/24/2020
NWAP
NEW APPLICATION ENTERED
08/25/2020
Continuous trademark protection
Get notified about every new filing that threatens EXPRESS SCRIPTS PHARMACY or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.